RU2021118423A - Hypertonic ophthalmic ointment - Google Patents
Hypertonic ophthalmic ointment Download PDFInfo
- Publication number
- RU2021118423A RU2021118423A RU2021118423A RU2021118423A RU2021118423A RU 2021118423 A RU2021118423 A RU 2021118423A RU 2021118423 A RU2021118423 A RU 2021118423A RU 2021118423 A RU2021118423 A RU 2021118423A RU 2021118423 A RU2021118423 A RU 2021118423A
- Authority
- RU
- Russia
- Prior art keywords
- ointment according
- paragraphs
- ointment
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
- 239000003885 eye ointment Substances 0.000 title claims 2
- 229940069265 ophthalmic ointment Drugs 0.000 title claims 2
- 239000002674 ointment Substances 0.000 claims 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 3
- 239000003995 emulsifying agent Substances 0.000 claims 3
- 229920002674 hyaluronan Polymers 0.000 claims 3
- 229960003160 hyaluronic acid Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 206010011033 Corneal oedema Diseases 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 201000004778 corneal edema Diseases 0.000 claims 2
- 208000002177 Cataract Diseases 0.000 claims 1
- 239000004166 Lanolin Substances 0.000 claims 1
- 229920002385 Sodium hyaluronate Polymers 0.000 claims 1
- 229940039717 lanolin Drugs 0.000 claims 1
- 235000019388 lanolin Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000012188 paraffin wax Substances 0.000 claims 1
- 239000008363 phosphate buffer Substances 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 229940010747 sodium hyaluronate Drugs 0.000 claims 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 229940099259 vaseline Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (15)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000010796 | 2018-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2021118423A true RU2021118423A (en) | 2023-01-09 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6527468B2 (en) | Artificial tears containing sodium hyaluronate and carboxymethylcellulose | |
| JP2006501133A5 (en) | ||
| AR089962A1 (en) | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR ELABORATION AND USE | |
| EA201792559A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION | |
| BRPI0821683B8 (en) | use of a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist to treat presbyopia, myopia, farsightedness, emmetropia and/or astigmatism, and/or to improve night or low light vision | |
| RU2014146121A (en) | METHODS FOR TREATING VASCULAR LEAF SYNDROME | |
| RU2015143898A (en) | OPHTHALMIC COMPOSITIONS FOR THE DELIVERY OF MEDICINES TO THE REAR SEGMENT OF THE EYE | |
| RU2012103538A (en) | COMPOSITIONS AND METHODS FOR INHIBITING JAK PATHWAY | |
| EA201001439A1 (en) | THREE-PHASE EMULSION (OPTIONS), METHOD FOR ITS PREPARATION AND APPLICATION | |
| RU2014140885A (en) | PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND TRAMADOL FOR OPHTHALMIC USE | |
| WO2017115238A1 (en) | Compositions for the treatment of presbyopia | |
| RU2008140117A (en) | MONOMER TGF-β AND ITS APPLICATION | |
| EA202091725A1 (en) | OPHTHALMIC COMPOSITIONS CONTAINING BILASTINE, BETA-CYCLODEXTRIN AND AT LEAST ONE GREATING SUBSTANCE | |
| RU2013107744A (en) | BIMATOPROST AND THYMOLOL SOLUTIONS NOT CONTAINING CONSERVANTS | |
| RU2009147168A (en) | NEW ACTIVE SUBSTANCE FOR HEALING AND ITS USE | |
| CN107496439A (en) | Efficient and safe chitosan derivative-based disinfectant and preparation method thereof | |
| RU2019139886A (en) | THERAPEUTIC AGAINST DYSFUNCTION OF MEIBOMIUM GLANDS | |
| EA201891730A1 (en) | OPHTHALMOLOGICAL COMPOSITION FOR APPLICATION IN THE TREATMENT OF OPHTHALMOLOGICAL DISORDERS RELATED TO CHANGES OF CORNER-CONJUNCTIVE SURFACE | |
| RU2691950C1 (en) | Compositions and methods for inhibiting inflammation and diseases using alginic acid-based antimicrobial compound | |
| MX2023009352A (en) | Methods for ophthalmic delivery of roflumilast. | |
| RU2021118423A (en) | Hypertonic ophthalmic ointment | |
| JP2017533228A5 (en) | ||
| WO2015094019A3 (en) | Pharmaceutical preparation for preventing and treating progressive myopia | |
| JP2021502337A5 (en) | ||
| RU2019118904A (en) | EYE DISTRIBUTION AND PHARMACOKINETICS OF LIFITEGRAST COMPOSITIONS |